ERNA - Eterna Therapeutics Inc.
0.1996
0.000 -0.150%
Share volume: 58,999
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$0.20
0.00
0.00%
Summary score
42%
Profitability
35%
Dept financing
50%
Liquidity
29%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2021 - 2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-100.7%
Return on sales
-269700%
Return on invested capital
0%
Total debt ratio
142.68%
Debt ratio change over timeo
0%
Current Ratio
0.51%
Quick Ratio
0%
Cash Position Ratio
0.39%
Short-term ratios 2024 - 2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-100.7%
Return on sales
-269700%
Return on invested capital
0%
Total debt ratio
142.68%
Debt ratio change over timeo
0%
Current Ratio
0.51%
Quick Ratio
0%
Cash Position Ratio
0.39%
Last quarter ratios 2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-162.07%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
217.63%
Debt ratio change over time
0%
Current Ratio
0.21%
Quick Ratio
0%
Cash Position Ratio
0.18%
Performance ratios (change over 4 years) 2021 - 2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ERNA | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 14.28% | 9.23% | 0% |
| Return on assets | -100.7% | 4.23% | 3.2% | 0% |
| Return on sales | -269700% | 27.89% | 25.03% | 0% |
| Return on invested capital | 0% | 8.36% | 9.37% | 0% |
| Profitability | 0% | 97% | 83% | 0% |
| Total debt ratio | 142.68% | 81.28% | 59.58% | 0% |
| Debt ratio change over time | 0% | -11.36% | -57.43% | 0% |
| Dept financing | 50% | 14% | 10% | 0% |
| Current Ratio | 0.51% | 1.23% | 1.12% | 0% |
| Quick Ratio | 0% | 0.95% | 0.88% | 0% |
| Cash Position Ratio | 0.39% | 0.12% | 0.5% | 0% |
| Liquididy | 28% | 55% | 75% | 0% |
| Short-term ratios | ERNA | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -100.7% | 4.32% | 3.49% | 0% |
| Return on sales | -269700% | 28.32% | 23.63% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 41% | 0% |
| Total debt ratio | 142.68% | 81.66% | 60.28% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 14% | 11% | 0% |
| Current Ratio | 0.51% | 1.23% | 1.12% | 0% |
| Quick Ratio | 0% | 0.95% | 0.88% | 0% |
| Cash Position Ratio | 0.39% | 0.12% | 0.5% | 0% |
| Liquididy | 30% | 56% | 71% | 0% |
